HIA
RXO icon

HFM Investment Advisors’s RXO RXO Stock Holding History

HFM Investment Advisors’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$20 – 1312
2025
Q1 		$20 Buy
+1
New +$22 ﹤0.01% 1152

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

HFM Investment Advisors's RXO Position: Q2 2025 in Review

HFM Investment Advisors sold out of RXO (RXO) in Q2 2025, closing a stake of 1 share — an estimated $20 sold.

HFM Investment Advisors first reported a position in RXO in Q1 2025 and held it in 1 quarter. The position peaked at $20 in Q1 2025. 267 funds tracked by Wall St. Rank hold RXO as of Q2 2025.

  • HFM Investment Advisors reported no remaining RXO position as of Q2 2025 after selling out during the quarter.
  • HFM Investment Advisors sold 1 RXO share in Q2 2025, an estimated $20.
  • HFM Investment Advisors first reported a position in RXO in Q1 2025 and held it in 1 quarter.
  • HFM Investment Advisors's RXO position peaked at $20 in Q1 2025.
  • 267 funds tracked by Wall St. Rank held RXO as of Q2 2025.

Based on HFM Investment Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.